Cure—Or Bust

LifeGuide Cure—or Bust Amid advances and setbacks in care, we must still aim for the end of HIV by Jeannie Wraight I recently read a rather angry reader...

The True End of AIDS

LifeGuide Trump Card Treatment and prevention are important, but an HIV cure will be the true end of AIDS by Jeannie Wraight Lately, we have been hearing a...

Broad Spectrum Antivirals: Part I

Spectrum Analysis Broad spectrum antivirals shift the drug model paradigm by Jeannie Wraight The recent spread of emerging pandemic viruses such as Zika and Ebola has increased...

Broad Spectrum Antivirals: Part II

Beyond One Bug, One Drug Broad spectrum antivirals shift the drug model paradigm, part II by Jeannie Wraight In the October issue of A&U, Destination: Cure explored...

amfAR Institute for HIV Cure Research: An Interview with Dr. Paul...

Hide & Seek Paul Volberding, MD, helps create synergy at the amfAR Institute for Cure Research by Jeannie Wraight The amfAR Institute for HIV Cure Research was...

HTVN 702: Vaccine Candidate

Step Forward Vaccine candidates like HTVN 702 are needed to build momentum by Jeannie Wraight If current HIV diagnoses rates persist, about 1 in 2 black men...

Cure Research Setback?

Shock and Kill Research unveils new info about latent HIV reservoirs, signaling a possible cure setback by Jeannie Wraight Amid several recent successes in the pursuit for...

Good News, Bad News

LifeGuide Good News, Bad News The HIV cure front faces disappointment mixed with hope by Jeannie Wraight The past year has been a difficult one in the HIV...

Cure News

News of the Day The latest reports on HIV cure research show momentum by Jeannie Wraight Here’s a look at some of the HIV cure headlines over...

Counting Cures

Destination: Cure by Jeannie Wraight Counting Cures Before we start tallying “cures,” let’s strive to define what we mean by “cured?” Several months ago a media frenzy...